You are here

R&D

AstraZeneca Provides An Inside Look Into R&D Practices

Forbes

Mon, 05/19/14 - 09:09 am

Cambridge Sees Pfizer Pursuit as Disrupting Science Hub

Bloomberg

Wed, 05/14/14 - 08:20 am

AstraZeneca and Incyte to study cancer drugs together

Yahoo/Reuters

Wed, 05/14/14 - 08:18 am

Pfizer CEO: R&D spend of new group would fall after Astra deal

Yahoo/Reuters

Tue, 05/13/14 - 07:55 am

UK labs play shrinking role in AstraZeneca drug portfolio

Reuters

Sun, 05/11/14 - 10:32 am

Cytomedix shutters R&D site after PhII failure

Fierce Biotech

Thu, 05/8/14 - 08:53 am

Loxo lands $24M venture round and a CSO for cancer drug research

Fierce Biotech

Wed, 05/7/14 - 08:24 am

Major Acquisitions Now A Necessary Part Of Pfizer's Future Strategy

Forbes

Tue, 05/6/14 - 09:22 am

AstraZeneca's tarnished R&D image haunts its fight against Pfizer

Fierce Biotech

Mon, 05/5/14 - 09:47 am

GSK's R&D staff hit with trade rumors spurred by Novartis' cancer pact

Fierce Biotech

Thu, 04/24/14 - 08:22 am

The Novartis-Glaxo-Lilly Swap’s Downside: Less Research

Bloomberg/Businessweek

Wed, 04/23/14 - 08:42 am

Potential Impact On R&D Of A Pfizer Takeover Of AstraZeneca

Forbes

Mon, 04/21/14 - 10:26 am

[video] Eli Lilly CEO: We keep investing in R&D

CNBC

Thu, 04/10/14 - 07:46 am

John Lechleiter

Tale Of Two Heart Drugs Show Challenges And Rewards In R&D

Forbes

Wed, 04/9/14 - 08:51 am

Eli Lilly and T1D to partner in diabetes research collaboration

The Fly on the Wall

Wed, 04/9/14 - 08:48 am

Novartis AG Seeks to Pump More Value into its R&D

Motley Fool

Mon, 04/7/14 - 10:25 am

Pharma giants jostle for the cancer R&D spotlight at AACR

Fierce Biotech

Fri, 04/4/14 - 09:39 am

GSK building up R&D, manufacturing and goodwill in Africa

Fierce Pharma

Mon, 03/31/14 - 04:43 pm

Glaxo Effort To Verify Gene Data Represents Step For Open Science

Forbes

Thu, 03/27/14 - 09:57 am

Three Misplaced Assumptions That Could End The Biotech Boom

Forbes

Thu, 03/27/14 - 08:15 am

Pages